Cyclophosphamide/fludarabine/rituximab: Acute myeloid leukaemia: case report

Author：  

Publisher： Adis International

ISSN： 0114-9954

Source： Reactions Weekly, Vol.1, Iss.1432, 2012-01, pp. : 19-19

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Cyclophosphamide/fludarabine/rituximab: Acute myeloid leukaemia: case report

By  

Reactions Weekly, Vol. 1, Iss. 1189, 2008-01 ,pp. : 14-14

Adis International

Access to resources Recommend Favorite

Cyclophosphamide/fludarabine/rituximab: Hypogammaglobulinaemia: case report

By  

Reactions Weekly, Vol. 1, Iss. 1204, 2008-01 ,pp. : 13-13

Adis International

Access to resources Recommend Favorite

Cyclophosphamide/fludarabine/rituximab: Reactivation of hepatitis B virus leading to fatal acute liver failure: case report

By  

Reactions Weekly, Vol. 1, Iss. 1232, 2008-01 ,pp. : 13-14

Adis International

Access to resources Recommend Favorite

Cyclophosphamide/fludarabine/rituximab: Fatal progressive multifocal leukoencephalopathy and toxoplasmosis: case report

By  

Reactions Weekly, Vol. 1, Iss. 1319, 2010-01 ,pp. : 20-20

Adis International

Access to resources Recommend Favorite

Cyclophosphamide/fludarabine/rituximab: Pulmonary hypertension (first report with fludarabine and rituximab): case report

By  

Reactions Weekly, Vol. 1, Iss. 1213, 2008-01 ,pp. : 15-16

Adis International

Access to resources Recommend Favorite